智通财经APP讯,天津发展(00882)发布公告,有关其间接非全资附属公司天津力生制药股份有限公司(力生制药)采纳股份回购方案及股票激励计划。于股份回购方案获采纳后,力生制药通过于深圳证券交易所以集中竞价交易方式,自2024年12月25日至2025年1月9日,按力生制药股份当时市价(其最高及最低回购价格分别为每股人民币18.50元及人民币17.28元)回购合共721万股其普通股股份,占其已发行股本...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.